| 9765065 |
Therapeutic substituted cyclopentanes |
David W. Old, Vinh X. Ngo, Mari Posner |
2017-09-19 |
|
| 9591935 |
Therapeutic substituted cyclopentanes |
David W. Old, Vinh X. Ngo, Mari Posner |
2017-03-14 |
|
| 8487091 |
Substituted cyclopentanes having prostaglandin activity |
Robert M. Burk, Mari Posner, Yariv Donde, David W. Old |
2013-07-16 |
$21,557,000 |
| 8193373 |
Therapeutic compounds |
Robert M. Burk, Mari Posner |
2012-06-05 |
$51,738,000 |
| 7964634 |
Therapeutic compounds |
Yariv Donde, Jeremiah H. Nguyen, Mari Posner, Robert M. Burk |
2011-06-21 |
$20,562,000 |
| 7960378 |
Therapeutic compounds |
Robert M. Burk, Mari Posner |
2011-06-14 |
$13,360,000 |
| 7872045 |
Combination therapy for glaucoma treatment |
Robert M. Burk, Scott M. Whitcup, Wha-Bin Im |
2011-01-18 |
$105,078,000 |
| 7612082 |
Prostaglandin EP4 antagonists |
Larry A. Wheeler, Michael E. Garst, Yanbin Liang, David F. Woodward, Achim H. Krauss +4 more |
2009-11-03 |
$70,839,000 |
| 7514462 |
ω-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
Robert M. Burk, Mari Posner |
2009-04-07 |
$63,930,000 |
| 7223746 |
Omega cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
Robert M. Burk, Mari Posner |
2007-05-29 |
$26,396,000 |
| 7183324 |
2,3,4-substituted cyclopentanones as therapeutic agents |
Yariv Donde, Mari Posner, Robert M. Burk, Michael E. Garst |
2007-02-27 |
$20,308,000 |
| 7022726 |
ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
Robert M. Burk, Mari Posner |
2006-04-04 |
$37,365,000 |
| 6956057 |
EP4 agonists as agents for lowering intraocular pressure |
David F. Woodward, Achim H. Krauss, Robert M. Burk, Mari Posner |
2005-10-18 |
$25,868,000 |
| 6767920 |
3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
Robert M. Burk, Mari Posner |
2004-07-27 |
$22,018,000 |
| 6710072 |
&OHgr;-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
Robert M. Burk, Mari Posner |
2004-03-23 |
$46,727,000 |
| 6586462 |
&ohgr;-Cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
Robert M. Burk, Mari Posner |
2003-07-01 |
$24,838,000 |
| 6538018 |
3, 7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
Robert M. Burk, Mari Posner |
2003-03-25 |
$24,228,000 |
| 6410591 |
3,7 or 3 and 7 thia or oxa prostanoic acid derivatives as agents for lowering intraocular pressure |
Robert M. Burk, Mari Posner |
2002-06-25 |
$24,585,000 |
| 6376533 |
Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
Robert M. Burk, Mari Posner |
2002-04-23 |
$69,873,000 |
| 6359181 |
Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents |
Robert M. Burk, Mari Posner |
2002-03-19 |
$13,893,000 |
| 6307092 |
Cyclopentane, 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents |
Robert M. Burk, Mari Posner |
2001-10-23 |
$22,647,000 |
| 6248783 |
Cyclopentane 1-hydroxy alkyl or alkenyl-2-one or 2-hydroxy derivatives as therapeutic agents |
Robert M. Burk, Mari Posner |
2001-06-19 |
$23,394,000 |
